Borealis Biosciences: Funding, Investors & Team (Sep 2026)
Borealis Biosciences is a company in the field of next-generation RNA medicines, specializing in molecular and cellular biology, vivarium space, chemistry, and analytical capabilities.
Borealis Biosciences has raised $180M across 2 funding rounds on record, the most recent a Series A of $30.0M announced in Dec 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Borealis Biosciences Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Borealis Biosciences Funding Rounds
Borealis Biosciences raised $150M in a Series A announced in Aug 2024.
4 months later, a Series A of $30.0M was announced in Dec 2024.
Borealis Biosciences Founders and Leadership Team
Contact details for the Borealis Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Borealis Biosciences Funding Compared to Other Biotechnology Startups
Borealis Biosciences' latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Borealis Biosciences in Biotechnology and Vancouver
Companies Similar to Borealis Biosciences
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Borealis Biosciences Funding FAQs
What does Borealis Biosciences do?
Borealis Biosciences is a company in the field of next-generation RNA medicines, specializing in molecular and cellular biology, vivarium space, chemistry, and analytical capabilities.
How much funding has Borealis Biosciences raised?
Borealis Biosciences has raised $180M across 2 rounds on record. The most recent is a Series A of $30.0M announced in Dec 2024.
When did Borealis Biosciences last raise funding?
Borealis Biosciences' most recent funding round on record is a Series A of $30.0M, announced in Dec 2024.
Who founded Borealis Biosciences?
FundedIQ lists David Powell (Founder) at Borealis Biosciences.
Where is Borealis Biosciences headquartered?
Borealis Biosciences is based in Vancouver, British Columbia, Canada.
How many employees does Borealis Biosciences have?
Borealis Biosciences is in the 11-50 employee band.
How does Borealis Biosciences' funding compare to other Biotechnology startups?
Borealis Biosciences' latest round of $30.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Borealis Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Borealis Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.